ConductScience.org, home

Comparison · NCT04196777-68c57110

Intervention vs Baseline Period: Percentage of Cases Who Underwent Clostridioides Difficile Testing

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Intervention vs Baseline Period: Percentage of Cases Who Underwent Clostridioides Difficile Testing. Trial comparisons, record NCT04196777-68c57110. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04196777-68c57110

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.00190.0003360.0107wilson
Risk in group 20.004720.002160.0103wilson
Risk difference, group 1 minus group 2-0.00281-0.008570.00636newcombe hybrid score
Risk ratio, group 1 over group 20.4040.04873.35log
Odds ratio, group 1 over group 20.4030.04843.35log
Number needed to treat, for one fewer participant with the outcome on Intervention than on Baseline Period356from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1InterventionThis data shows the proportion of cases who had C. difficile testing within 30 days after the procedure during the 12-month audit-and-feedback period.1525OG000
Group 2Baseline PeriodThis data shows the proportion of cases who had C. difficile testing within 30 days after the procedure during the 24-month pre-intervention period.61,272OG001

Outcome

Type
SECONDARY
Title
Percentage of Cases Who Underwent Clostridioides Difficile Testing
Description
Clostridioides difficile testing is defined as any laboratory test ordered for C. difficile within 30-days of the patient's urologic procedure. For this specific outcome measure, the numerator will be the number of patients who underwent C. difficile testing within 30-days of the procedure, and the denominator will be all patients at the site who underwent a qualifying urologic procedure.
Time frame
Within 30-days of the urologic procedure
Population

Source ClinicalTrials.gov

Trial

Title
Audit-and-feedback to Improve Antimicrobial-prescribing Among Urologists
NCT number
NCT04196777
Phases
NA
Conditions
Urologic Diseases, Antibacterial Drug Adverse Reaction
Interventions
Audit-and-feedback
Lead sponsor
Iowa City Veterans Affairs Medical Center
Results first posted
2024-09-19

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04196777-68c57110